Study at a glance
What did researchers compare about vitamin D, asthma and breathing?
Researchers analysed 435,040 UK Biobank participants aged 37 to 73. They compared vitamin D blood levels with reported doctor-diagnosed asthma, wheeze during the previous year, past asthma hospital admissions and spirometry. Spirometry measures how much air a person can force out and how quickly. This was an observational study, not a supplement trial.
Were higher vitamin D levels linked with better breathing results?
Higher vitamin D levels were linked with modestly better breathing-test results and lower odds of asthma and recent wheeze. The link with a history of asthma hospitalisation was not consistently favourable. A symptom, a breathing-test result and a hospital admission are different outcomes, so a positive result for one cannot be assumed for the others.
Does this show that vitamin D improves breathing?
No. The study did not establish which came first. Poor lung and airway health could reduce outdoor activity or affect diet and supplement use. Other factors could influence both vitamin D and breathing. Allowing for recorded differences between people helps, but cannot remove every possible explanation. A large sample makes estimates more precise without proving cause and effect.
Can these findings guide asthma treatment with vitamin D?
Most participants were White, and people with very high or very low vitamin D measurements were excluded. Past admissions could have occurred long before the blood test. The paper also contained reporting inconsistencies, including the scale of one breathing-test result. These findings do not establish that supplements prevent asthma, reduce severe episodes or improve breathing, and they do not identify a personal vitamin D target.
Read the full article below ↓A UK Biobank analysis linked higher serum vitamin D status with modestly better spirometry and lower odds of asthma and recent wheeze. The pattern did not extend consistently to a history of asthma hospitalisation. Because the study was cross-sectional, these associations cannot establish that vitamin D prevented disease or that supplementation would improve breathing. For the companion appraisal, see Vitamin D Status, Spirometry and Asthma in UK Biobank: Study Summary.
The population and the question
Zhu and colleagues analysed 435,040 UK Biobank participants aged 37 to 73 years. Of these, 58,635 reported doctor-diagnosed asthma and 376,405 did not. The study asked whether measured 25-hydroxyvitamin D was associated with asthma, lung-function measurements, recent wheeze and a history of asthma admission. These are related but distinct questions: having a diagnosis, experiencing a symptom and requiring hospital care do not describe the same aspect of respiratory health.
The analytic population was selected from the wider Biobank cohort. The researchers excluded 63,710 people with missing vitamin D measurements or concentrations outside the first and ninety-ninth percentiles, then excluded 3,755 with missing age, sex, body mass index or smoking information. Excluding extreme concentrations limits what the analysis can say about either end of the vitamin D range. It also means that the findings should not be treated as a direct assessment of every person with severe deficiency.
Participants had a mean age of about 56.5 years, and approximately 91% were classified as White. The asthma group had a higher mean body mass index and was more often female than the comparison group. These starting differences explain why adjustment was needed and help define generalisability. The large sample supplies precision within this selected population; it does not guarantee that the same estimates apply to children, very old adults or populations with different characteristics.
What the investigators actually measured
The exposure was serum 25-hydroxyvitamin D, measured using a competitive chemiluminescent immunoassay. Participants were not allocated to a blood concentration or a supplement dose. The paper analysed vitamin D as a continuous variable, in quartiles and in three categories: below 25, 25 to 50 and above 50 nmol/L. Its label “optimal” for the highest category is an analytical label, not proof that this concentration is an effective treatment target.
Asthma was identified from participants reporting that a doctor had diagnosed it. Recent wheeze meant wheezing or whistling in the chest during the preceding year. Asthma hospitalisation meant ever having an admission with a main diagnosis compatible with asthma, excluding admissions attributed primarily to chronic obstructive pulmonary disease. A lifetime admission history and a symptom during the past year use different time windows. Neither should be presented as a prospectively observed response to the baseline blood test.
Spirometry measured forced expiratory volume in one second, or FEV1, and forced vital capacity, or FVC. FEV1 describes the air expelled during the first second; FVC describes the full forced breath. Their ratio helps describe airflow limitation. The protocol used two or three blows, with a third unnecessary when the first two met the stated reproducibility criterion. Testing was deferred or excluded for specified recent illnesses, procedures and other conditions. Thus, the lung-function analysis depends on acceptable manoeuvres as well as on having a blood measurement.
These measurements belong to Vitamin D and Lung Function, but they do not directly measure airway inflammation, infection resistance or receptor activity. A larger exhaled volume and a lower probability of hospital admission would be different findings, requiring separate evidence.
Adjustment and the asthma association
The reported models adjusted for age, sex, body mass index, ethnicity, income, education, smoking status and vitamin D supplement use. FEV1 and FVC models additionally included height and height squared, because body size influences lung volume. These adjustments compare people who are more similar on the recorded factors. They do not randomise exposure or remove confounding by factors that were unmeasured, measured imprecisely or omitted from the model.
For a one-standard-deviation higher vitamin D concentration, the adjusted odds ratio for asthma was 0.960, with a 95% confidence interval of 0.951 to 0.970. The standard deviation in the full sample was about 19.7 nmol/L. The estimate therefore describes a modest between-person association across a specified difference in concentration. It is not the effect of prescribing a dose or raising an individual’s blood level by that amount.
The categorical findings pointed in the same direction. Compared with concentrations below 25 nmol/L, the adjusted odds ratios were 0.936 for 25 to 50 nmol/L and 0.902 for above 50 nmol/L. The corresponding unadjusted asthma proportions were 15.1%, 13.8% and 12.7%. These observed proportions help communicate scale, but their differences cannot be interpreted as numbers of cases prevented by vitamin D. Nor is an odds ratio interchangeable with a risk ratio or a percentage-point change.
Recent wheeze and hospitalisation diverged
Among participants with asthma, the adjusted odds ratio for recent wheeze per standard-deviation higher vitamin D was 0.914, with a 95% confidence interval of 0.897 to 0.931. In the lowest and highest vitamin D categories, respectively, 66.8% and 58.6% reported wheeze. The adjusted highest-versus-lowest category odds ratio was 0.801. This provides evidence of a symptom association, while retaining the same uncertainties about temporal order and shared causes.
Hospitalisation did not show the same favourable pattern. The adjusted odds ratio per standard-deviation increase was 1.018, with a 95% confidence interval of 0.999 to 1.036. The main three-category comparisons were not statistically significant. One highest-versus-lowest quartile comparison was borderline in the opposite direction, with an odds ratio of 1.050 and a reported P value of 0.048, while the overall quartile trend was not significant. Selecting that comparison alone would overstate a heterogeneous set of results.
The outcome timing offers one reason for caution. An admission may have occurred well before the vitamin D measurement, whereas recent wheeze concerns a shorter interval. A contemporary blood result cannot reconstruct exposure throughout the years leading to an earlier admission. The study therefore does not establish that higher vitamin D prevented severe episodes, even though some symptom and spirometric associations were favourable.
Spirometry results and their units
In participants with asthma, Table 3 reported adjusted coefficients of 1.328 mL for FEV1 and 2.018 mL for FVC per nmol/L higher vitamin D. The respective 95% confidence intervals were 0.575 to 2.080 and 1.127 to 2.908 mL. These coefficients describe average differences within the fitted observational models. They do not tell a patient how much lung volume would be gained through supplementation, and extrapolating across a large concentration change would add assumptions about the relationship’s shape.
For FEV1/FVC, the table reports 0.006 percentage points per nmol/L, with a 95% confidence interval of 0.002 to 0.010. The narrative instead states 0.6%, an inconsistent scale. This appraisal retains the table value and flags the discrepancy rather than silently repeating the larger number. Checking the unit is essential because a ratio, a percentage-point difference and a relative percentage change are not equivalent quantities.
The sex-stratified results were also not uniformly significant. The FEV1 and ratio coefficients reached the stated significance threshold in women but not in men; the FVC coefficient did so in both. That does not, by itself, prove a biological difference between sexes. A significant estimate in one group and a nonsignificant estimate in another is not a direct test that their effects differ. Precision and the uncertainty around both estimates must remain part of the comparison.
Subgroups and missing-data checks
The supplementary tables examined age, body mass index and smoking groups. Some point estimates appeared stronger in older participants, people with obesity and current or former smokers. However, not every within-group comparison was significant. For example, in participants younger than 50, the highest-versus-lowest three-category asthma comparison had an odds ratio of 0.961 with a confidence interval of 0.913 to 1.012. This does not justify describing every subgroup as showing a statistically established association.
The sensitivity analysis restored participants with missing covariates through multiple imputation, increasing the sample to 438,795. Its asthma odds ratio per standard-deviation higher vitamin D was 0.965, with a 95% confidence interval of 0.956 to 0.974, compared with 0.960 in the complete-case analysis. The similar direction makes exclusion of those particular missing covariates a less likely sole explanation for the main result. It cannot correct unmeasured confounding, restore excluded extreme vitamin D values or prove that the imputation assumptions were correct.
What the study contributes to causal understanding
The central limitation is temporal order. Poor respiratory health could reduce outdoor activity or change diet and supplement use, while other influences could affect both respiratory health and vitamin D status. Correlation vs Causation in Vitamin D explains why adjustment cannot distinguish all these possibilities. A narrow confidence interval describes statistical precision under the chosen model; it does not eliminate bias or establish the direction of causation.
The distinction in Vitamin D Status vs Vitamin D Effect is also directly relevant. A circulating precursor concentration does not measure active hormone exposure in each airway cell. Vitamin D Activation and Vitamin D Receptors describe additional biological steps. This cohort did not measure those steps and establish that they mediated its respiratory associations.
The topics covered by Vitamin D and Immune Modulation, Vitamin D and Mucosal Defence and Vitamin D and Inflammatory Signalling supply reasons to investigate a respiratory relationship. They do not convert the cohort into a mechanistic experiment. Testing mediation would require relevant tissue or immune measurements and a design capable of establishing the proposed sequence.
A further reporting limitation is that the methods describe the statistical approach broadly as logistic regression even though the lung-function table presents continuous-outcome coefficients. The paper also contains the ratio-unit inconsistency noted above. These issues call for care when reproducing exact numerical claims. They are not grounds for inventing a corrected model or discarding every association; they define what can be read confidently from the published report and what would require clarification or reanalysis.
Conclusion
This large observational study found modest associations between vitamin D status, asthma prevalence, recent wheeze and spirometry. Its hospitalisation findings were not consistently favourable, and reporting discrepancies limit confidence in uncritical reuse of individual numbers. The study supports a population-level relationship worth investigating. It does not establish prevention of asthma, improvement in breathing through supplementation or a personal vitamin D target.
Sources and publication details
Vitamin D status and asthma, lung function, and hospitalization among British adults. Zhu Y and colleagues. Frontiers in Nutrition. 2022;9:954768. DOI: 10.3389/fnut.2022.954768. PMID: 36034921.
Related reading
A molecular systems architecture of asthma
Asthma is a heterogeneous inflammatory disease driven by complex genetic, immunological, environmental, and neuro-immune interactions.
Original paper ↗Read more →Analysis of the characteristics of blood inflammatory cytokines and their influencing factors in acute exacerbations of allergic asthma in children
Exploring the characteristics of serum inflammatory cytokine changes during acute exacerbations of pediatric allergic asthma, and analyzing factors influencing poor asthma control and predictive indicators.
Original paper ↗Read more →Association of 25-hydroxy vitamin D with asthma and its severity in children: a case-control study
D levels with asthma and with the severity of asthma were evaluated.
Original paper ↗Read more →Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes
Prior studies suggest a role for a variant (rs5743836) in the promoter of toll-like receptor 9 (TLR9) in asthma and other inflammatory diseases.
Original paper ↗Read more →Diet, occupational exposure and early asthma incidence among bakers, pastry makers and hairdressers
The natural history of occupational asthma (OA) is influenced by many determinants.
Original paper ↗Read more →Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
Describing the association between the dose of ICS and duration of therapy on the above parameters were secondary objectives.
Original paper ↗Read more →Effect of Monthly Vitamin D Supplementation on Preventing Exacerbations of Asthma or Chronic Obstructive Pulmonary Disease in Older Adults: Post Hoc Analysis of a Randomized Controlled Trial
Randomized controlled trials have suggested that vitamin D supplementation can prevent asthma and chronic obstructive pulmonary disease (COPD) exacerbations.
Original paper ↗Read more →Efficacy and safety of vitamin D in the treatment of asthma: an overview of systematic reviews and meta-analyses
This umbrella review aimed to evaluate the efficacy and safety of vitamin D supplementation as an adjunctive treatment for asthma and to assess the credibility of the existing evidence.
Original paper ↗Read more →Exploring the causal relationship between 25-hydroxyvitamin D and asthma: A bidirectional Mendelian randomization study
The role of 25-hydroxyvitamin D (25(OH)D) in disease has attracted much attention.
Original paper ↗Read more →Exposure to Vitamin D Fortification Policy in Prenatal Life and the Risk of Childhood Asthma: Results from the D-Tect Study
The objective of this study was to examine if children born to women exposed to the margarine fortification policy with a small dose of extra vitamin D during pregnancy had a reduced risk of developing asthma until age 9 years, compared to children born to unexposed women.
Original paper ↗Read more →Genetic Diversity in Bronchial Asthma Susceptibility: Exploring the Role of Vitamin D Receptor Gene Polymorphisms in Varied Geographic Contexts
Bronchial asthma (BA) exhibits varying prevalence across global populations, prompting a comprehensive investigation into genetic and environmental determinants.
Original paper ↗Read more →Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids)
A second potential limitation relates to the fact that pubertal status was assessed by participants themselves, rather than by health professionals, whose judgement may be more objective.
Original paper ↗Read more →Multivitamin consumption and childhood asthma: a cross-sectional study of the NHANES database
Dietary intakes of vitamins are associated with asthma.
Original paper ↗Read more →Non‐pharmacological interventions for asthma prevention and management across the life course: Umbrella review
We aim to comprehensively evaluate and synthesize existing evidence regarding the effectiveness of various NPIs throughout the life course.
Original paper ↗Read more →Partial Least Squares Discriminant Analysis and Bayesian Networks for Metabolomic Prediction of Childhood Asthma
The standard PLS-DA approach had impressive accuracy for the prediction of age three asthma with an Area Under the Curve Convex Hull (AUCCH) of 81%.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Concentrations are Associated with Polyunsaturated Fatty Acid Metabolites in Young Children: Results from the Vitamin D Antenatal Asthma Reduction Trial
The objective of the current analysis was to identify metabolites and metabolic pathways associated with plasma 25-hydroxyvitamin D [25(OH)D] concentrations.
Original paper ↗Read more →Prenatal vitamin D supplementation reduces risk of asthma/recurrent wheeze in early childhood: A combined analysis of two randomized controlled trials
We recently published two independent randomized controlled trials of vitamin D supplementation during pregnancy, both indicating a >20% reduced risk of asthma/recurrent wheeze in the offspring by 3 years of age.
Original paper ↗Read more →Prevalence and association of elevated total serum IgE levels with ICU admissions and poor asthma control: a retrospective study in a tertiary hospital in Saudi Arabia
This study aimed to determine the prevalence of elevated serum Immunoglobulin E (IgE) levels among adult patients with asthma and to investigate the association between IgE levels and hospital admissions, ICU admissions, asthma control, and other clinical outcomes.
Original paper ↗Read more →Risk Factors Affecting Development and Persistence of Preschool Wheezing: Consensus Document of the Emilia-Romagna Asthma (ERA) Study Group
In terms of health care burden, preschool children with wheeze show double the rate of access to the emergency department and five times the rate of hospital admissions compared with school-age asthmatics.
Original paper ↗Read more →Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency
Clinical parameters of asthma control and 25-hydroxyvitamin D (25(OH)D) serum concentrations were evaluated in 280 adult asthma patients (mean ± SD: 45.0 ± 13.8 yrs., 40% male, FEV1 74.9 ± 23.4%, 55% severe, 51% uncontrolled).
Original paper ↗Read more →Suboptimal Serum 25-Hydroxy-Vitamin D Is Associated with a History of Recent Disease Exacerbation in Pediatric Patients with Bronchial Asthma or Asthma-Suggestive Recurrent Wheezing
We aimed to survey the prevalence of serum 25-OH-VitD deficiency and analyze whether suboptimal levels were associated with asthma severity factors.
Original paper ↗Read more →Original sources
Vitamin D status and asthma, lung function, and hospitalization among British adults
Published in Zhu Y and colleagues. Frontiers in Nutrition (2022).
Publication details
Vitamin D status and asthma, lung function, and hospitalization among British adults. Zhu Y and colleagues. Frontiers in Nutrition. 2022;9:954768. DOI: 10.3389/fnut.2022.954768. PMID: 36034921.